A Tampa doctor has used the new ASD device since November and has done the procedure for seven patients since then. St. Joseph's Children's Hospital in Tampa has started using a new device to ...

The device (Gore Cardioform ASD Occluder) was approved based on the results of the Gore ASSURED Clinical Study of its performance in patients aged 2 to 84 years with atrial septal defects and ...

Walsh, KP, Tofeig M, Kitchiner DJ, Peart I, Arnold R. Comparison of the Sideris and Amplatzer septal occlusion devices. Am J Cardiol 1999 Mar 15; 933-6 Four atrial septal defect occluders (ASD ...

Results showed a statistically significant 77% relative reduction in recurrent ischemic stroke in patients who underwent PFO closure with a Gore device in conjunction with antiplatelet therapy vs ...

Instead of open heart surgery--in 2016 the FDA approved an ASD closure device--to close the hole in a quick, outpatient procedure.

TCT 1307: Puncture and Deployment of a Second Trans-ASD Closure Device: A Treatment Strategy for Displaced ASD Occluder in a High Surgical Risk Patient With Complex Anatomy ...

Atrial septal defect (ASD) and ventricular septal defect (VSD) are both conditions that involve incorrect blood flow within the heart.

TCT 200: Transthoracic Echocardiography Guided Device Closure of Atrial Septal Defect (ASD) in Adult and Pediatric Population ...

The breakthrough device designation label noted the intended use of the platform will be applicable to patients between birth and age 21 years, with risk assessment for ASD to be conducted between ...

Instead of open heart surgery--in 2016 the FDA approved an ASD closure device--to close the hole in a quick, outpatient procedure.